BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akula SM, Bolin P, Cook PP. Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene. RNA Biol 2021;:1-11. [PMID: 34904915 DOI: 10.1080/15476286.2021.2010959] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Borrmann M, Brandes F, Kirchner B, Klein M, Billaud J, Reithmair M, Rehm M, Schelling G, Pfaffl MW, Meidert AS. Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1129766] [Reference Citation Analysis]
2 Liang Y, Fang D, Gao X, Deng X, Chen N, Wu J, Zeng M, Luo M. Circulating microRNAs as emerging regulators of COVID-19. Theranostics 2023;13:125-47. [PMID: 36593971 DOI: 10.7150/thno.78164] [Reference Citation Analysis]
3 Formosa A, Turgeon P, dos Santos CC. Role of miRNA dysregulation in sepsis. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00527-z] [Reference Citation Analysis]
4 Akula SM, Williams JF, Pokhrel LR, Bauer AN, Rajput S, Cook PP. Cellular miR-6741-5p as a Prognostic Biomarker Predicting Length of Hospital Stay among COVID-19 Patients. Viruses 2022;14. [PMID: 36560686 DOI: 10.3390/v14122681] [Reference Citation Analysis]
5 Shirvani H, Jafari H, Moravveji SS, Faranghizadeh FA, Talebi M, Ghanavi J, Esfandi F, Najafi S, Moghadam MN, Farnia P, Zarch SMA. Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance. Int J Biol Macromol 2022:S0141-8130(22)02036-0. [PMID: 36152703 DOI: 10.1016/j.ijbiomac.2022.09.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Devadoss D, Acharya A, Manevski M, Houserova D, Cioffi MD, Pandey K, Nair M, Chapagain P, Mirsaeidi M, Borchert GM, Byrareddy SN, Chand HS. Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype. iScience 2022;25:104685. [PMID: 35789750 DOI: 10.1016/j.isci.2022.104685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Moatar AI, Chis AR, Marian C, Sirbu I. Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease. IJMS 2022;23:9239. [DOI: 10.3390/ijms23169239] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Dias TR, Dias F, Teixeira AL, Sousa H, Oliveira J, Medeiros R. MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 2022;11:2279. [DOI: 10.3390/cells11152279] [Reference Citation Analysis]
9 Mortazavi-Jahromi SS, Aslani M. Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation. Int Immunopharmacol 2022;110:109040. [PMID: 35839566 DOI: 10.1016/j.intimp.2022.109040] [Reference Citation Analysis]
10 Li S, Zhang X, Yao Y, Zhu Y, Zheng X, Liu F, Feng W. Inducible miR-150 Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by Targeting Viral Genome and Suppressor of Cytokine Signaling 1. Viruses 2022;14:1485. [DOI: 10.3390/v14071485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bueno LCM, Paim LR, Minin EOZ, da Silva LM, Mendes PR, Kiyota TA, Schreiber AZ, Bombassaro B, Mansour E, Moretti ML, Chow JT, Salmena L, Coelho-filho OR, Velloso LA, Nadruz W, Schreiber R. Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19. Viruses 2022;14:1363. [DOI: 10.3390/v14071363] [Reference Citation Analysis]
12 Pollet K, Garnier N, Szunerits S, Madder A, Hober D, Engelmann I. Host miRNAs as biomarkers of SARS-CoV-2 infection: a critical review. Sens Diagn 2022. [DOI: 10.1039/d2sd00140c] [Reference Citation Analysis]
13 Pokhrel LR, Williams F, Cook PP, O'Rourke D, Murray G, Akula SM. Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model. Drug Deliv Transl Res 2022;12:3007-16. [PMID: 35441321 DOI: 10.1007/s13346-022-01166-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]